Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe
- PMID: 22474219
- PMCID: PMC3334361
- DOI: 10.1093/cid/cis118
Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe
Abstract
Background: We have previously described the presentation of epidermodysplasia verruciformis (EV)-like eruptions in almost a quarter of hospitalized adolescents with vertically-acquired human immunodeficiency virus (HIV) infection in Harare, Zimbabwe, a region with a high prevalence of HIV infection.
Methods: We performed a clinical case note review and skin biopsy from affected sites in 4 HIV-infected adolescents with EV-like lesions in Harare. Biopsies were processed for histology and for human papillomavirus (HPV) typing.
Results: All patients had long-standing skin lesions that pre-dated the diagnosis of HIV by several years. The histology of skin biopsies from all patients was consistent with EV. In each biopsy, EV-associated β-HPV type 5 was identified (additionally, type 19 was found in 1 biopsy). Cutaneous wart-associated HPV types 1 and 2 were detected in all biopsies, together with genital lesion-associated HPV types 6, 16, and 52, (as well as ≥3 other genital lesion-associated HPV types). Despite immune reconstitution with combination antiretroviral therapy (cART), there was no improvement in EV-like lesions in any patient.
Conclusions: EV is a disfiguring and potentially stigmatizing condition among this patient group and is difficult to treat; cART appears to have no impact on the progression of skin disease. Among adolescents with longstanding HIV-induced immunosuppression and with high levels of sun exposure, close dermatological surveillance for potential skin malignancy is required.
Figures


Similar articles
-
Acquired epidermodysplasia verruciformis in an HIV-positive patient.Int J STD AIDS. 2016 Oct;27(11):1023-5. doi: 10.1177/0956462415613933. Epub 2015 Oct 28. Int J STD AIDS. 2016. PMID: 26516132
-
Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease.Br J Dermatol. 1991 Jan;124(1):79-83. doi: 10.1111/j.1365-2133.1991.tb03286.x. Br J Dermatol. 1991. PMID: 1847068
-
HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV 25.J Cutan Med Surg. 2004 Mar-Apr;8(2):110-5. doi: 10.1007/s10227-003-0100-6. Epub 2004 May 3. J Cutan Med Surg. 2004. PMID: 15129315
-
Recent advances in cutaneous HPV infection.J Dermatol. 2023 Mar;50(3):290-298. doi: 10.1111/1346-8138.16697. Epub 2023 Jan 5. J Dermatol. 2023. PMID: 36601717 Review.
-
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.Int J Dermatol. 2022 Nov;61(11):1325-1335. doi: 10.1111/ijd.15857. Epub 2021 Aug 17. Int J Dermatol. 2022. PMID: 34403500 Review.
Cited by
-
Acquired Epidermodysplasia Verruciformis During Highly Active Antiretroviral Therapy.Indian J Dermatol. 2022 May-Jun;67(3):316. doi: 10.4103/ijd.IJD_747_20. Indian J Dermatol. 2022. PMID: 36386098 Free PMC article. No abstract available.
-
What's new in HIV dermatology?F1000Res. 2019 Jun 28;8:F1000 Faculty Rev-980. doi: 10.12688/f1000research.16182.1. eCollection 2019. F1000Res. 2019. PMID: 31297183 Free PMC article. Review.
-
Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.Oral Dis. 2016 Apr;22 Suppl 1(Suppl 1):181-92. doi: 10.1111/odi.12418. Oral Dis. 2016. PMID: 27109286 Free PMC article.
-
Cutaneous squamous cell carcinoma in vertically acquired HIV and epidermodysplasia verruciformis.South Afr J HIV Med. 2022 Jun 27;23(1):1368. doi: 10.4102/sajhivmed.v23i1.1368. eCollection 2022. South Afr J HIV Med. 2022. PMID: 35923606 Free PMC article.
-
Recalcitrant hyperkeratotic verrucae in a renal transplant recipient clearing with cessation of immunosuppression.JAAD Case Rep. 2018 May 4;4(5):471-473. doi: 10.1016/j.jdcr.2017.09.025. eCollection 2018 Jun. JAAD Case Rep. 2018. PMID: 29984286 Free PMC article. No abstract available.
References
-
- Gul U, Kilic A, Gonul M, Cakmak SK, Bayis SS. Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol. 2007;46:1069–72. - PubMed
-
- Jablonska S, Orth G, Jarzabek-Chorzelska M, et al. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus? J Invest Dermatol. 1979;72:114–19. - PubMed
-
- Ramoz N, Taieb A, Rueda LA, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol. 2000;114:1148–53. - PubMed
-
- Bonamigo R, Maldonado G, Londero RM, Cartell A. Epidermodysplasia verruciformis–like disorder in a teenager with HIV and HCV infections. Pediatr Dermatol. 2007;24:456–7. - PubMed
-
- Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis–like eruption complicating human immunodeficiency virus infection. Br J Dermatol. 1998;139:122–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical